Despite continuing financial success, many big pharmaceutical companies are facing an uncertain future. Merging basic and clinical research in a determined effort to fully elucidate the molecular mechanisms of disease and thus to develop effective drugs with fewer side effects is the tough journey ahead that big pharma needs to pursue to ensure a brighter future
Abstract: Pharmaceutical business relies more on innovation and research than other types of busines...
<p>M&As that led to the current 12 largest Big Pharma firms. (source: SDC Platinum Database (Thomson...
How do incumbent firms respond over time to a potentially disruptive technology? This article docume...
Pharmaceutical and medicinal R&D projects have evolved during recent decades into extremely intricat...
Despite continuing financial success, many big pharmaceutical companies are facing an uncertain futu...
This paper examines the Pharmaceutical (Pharma) industry and the changes that have occurred particul...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characteris...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
By any standard, the pharmaceutical industry's history has been a successful one. In addition to its...
Recent years have seen exciting breakthroughs in biomedical sciences that are producing truly novel ...
Big pharma is increasingly looking to academia for new drug leads and technologies; meanwhile univer...
peer reviewedINTRODUCTION: Due to changing macro and micro factors, expiring patents and falling ne...
In the research-intensive pharmaceutical industry, two rationales for M&A prevail. First, deals may ...
Trabajo presentado al DRUID Society Conference on Innovation and Competitiveness - Dynamics of Organ...
The traditional heavyweights or big pharmas of the modern pharmaceutical industry are facing unprece...
Abstract: Pharmaceutical business relies more on innovation and research than other types of busines...
<p>M&As that led to the current 12 largest Big Pharma firms. (source: SDC Platinum Database (Thomson...
How do incumbent firms respond over time to a potentially disruptive technology? This article docume...
Pharmaceutical and medicinal R&D projects have evolved during recent decades into extremely intricat...
Despite continuing financial success, many big pharmaceutical companies are facing an uncertain futu...
This paper examines the Pharmaceutical (Pharma) industry and the changes that have occurred particul...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characteris...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
By any standard, the pharmaceutical industry's history has been a successful one. In addition to its...
Recent years have seen exciting breakthroughs in biomedical sciences that are producing truly novel ...
Big pharma is increasingly looking to academia for new drug leads and technologies; meanwhile univer...
peer reviewedINTRODUCTION: Due to changing macro and micro factors, expiring patents and falling ne...
In the research-intensive pharmaceutical industry, two rationales for M&A prevail. First, deals may ...
Trabajo presentado al DRUID Society Conference on Innovation and Competitiveness - Dynamics of Organ...
The traditional heavyweights or big pharmas of the modern pharmaceutical industry are facing unprece...
Abstract: Pharmaceutical business relies more on innovation and research than other types of busines...
<p>M&As that led to the current 12 largest Big Pharma firms. (source: SDC Platinum Database (Thomson...
How do incumbent firms respond over time to a potentially disruptive technology? This article docume...
DOI
Add to ORKG